SIGN UP
LOG IN
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga·08/01/2025 12:07:59
Listen to the news
Gainers
- BioXcel Therapeutics (NASDAQ:BTAI) shares increased by 35.9% to $1.78 during Friday's pre-market session. The company's market cap stands at $7.9 million.
- 4D Molecular Therapeutics (NASDAQ:FDMT) shares increased by 30.66% to $5.88. The company's market cap stands at $208.4 million.
- Kazia Therapeutics (NASDAQ:KZIA) stock rose 24.94% to $10.47. The company's market cap stands at $46.8 million.
- Avalo Therapeutics (NASDAQ:AVTX) stock moved upwards by 17.96% to $9.31. The company's market cap stands at $85.4 million.
- Bolt Biotherapeutics (NASDAQ:BOLT) shares moved upwards by 16.46% to $6.58. The market value of their outstanding shares is at $10.8 million.
- Fulgent Genetics (NASDAQ:FLGT) stock moved upwards by 14.95% to $19.75. The company's market cap stands at $530.2 million. As per the press release, Q2 earnings came out today.
Losers
- Ontrak (NASDAQ:OTRK) shares fell 16.9% to $0.25 during Friday's pre-market session. The market value of their outstanding shares is at $2.1 million.
- Zynex (NASDAQ:ZYXI) shares decreased by 12.11% to $1.96. The market value of their outstanding shares is at $67.4 million. As per the news, the Q2 earnings report came out yesterday.
- CalciMedica (NASDAQ:CALC) shares decreased by 11.92% to $3.03. The market value of their outstanding shares is at $48.0 million.
- Pheton Holdings (NASDAQ:PTHL) shares decreased by 11.2% to $0.79. The market value of their outstanding shares is at $12.8 million.
- NexGel (NASDAQ:NXGL) stock declined by 11.11% to $2.0. The company's market cap stands at $17.2 million.
- Avantor (NYSE:AVTR) stock fell 10.72% to $12.0. The company's market cap stands at $9.1 billion. As per the press release, Q2 earnings came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.